Merck & Co., Inc.
MRK
$148.35
-$1.19-0.80%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.97% | -0.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.97% | -0.70% | |||
| Cost of Revenue | 6.53% | -9.78% | |||
| Gross Profit | 0.55% | 2.53% | |||
| SG&A Expenses | 8.22% | -6.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 66.49% | -9.31% | |||
| Operating Income | -100.64% | 16.97% | |||
| Income Before Tax | 80.67% | -203.33% | |||
| Income Tax Expenses | -7.76% | 54.80% | |||
| Earnings from Continuing Operations | 68.49% | -243.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -33.33% | 200.00% | |||
| Net Income | 68.51% | -243.10% | |||
| EBIT | -100.64% | 16.97% | |||
| EBITDA | -81.43% | 13.22% | |||
| EPS Basic | 68.49% | -244.03% | |||
| Normalized Basic EPS | -108.63% | 18.34% | |||
| EPS Diluted | 68.58% | -244.43% | |||
| Normalized Diluted EPS | -108.63% | 18.34% | |||
| Average Basic Shares Outstanding | -0.08% | -0.64% | |||
| Average Diluted Shares Outstanding | -0.08% | -0.64% | |||
| Dividend Per Share | 0.00% | 4.94% | |||
| Payout Ratio | -2.23% | -1.73% | |||